Description:
MT-I is a synthetic analog of a-Melanocyte Stimulating Hormone (a-MSH) specifically developed for research into melanocortin receptor pathways. This linear heptapeptide demonstrates potent agonist activity at melanocortin receptors MCIR and MC3-5R, making it valuable for studying pigmentary responses, metabolic regulation, and neuroimmunomodulatory processes in
experimental models. In controlled research environments, MT-I has shown significant potential for stimulating melanogenesis through CAMP-mediated pathways in melanocyte cell cultures. The peptide appears to interact with key melanocortin receptors involved in pigment formation, appetite regulation, and inflammatory response modulation, providing researchers with a valuable tool for investigating melanocortin system function. This vial contains 10mg of lyophilized MT-I peptide, prepared under strict laboratory conditions for consistent research applications in dermatological, metabolic, and neurological studies.
Specifications:
unit Size: 10mg (lyophilized powder, single vial)
Form: White crystalline lyophilized powder
Molecular Weight: -1.1 kDa
Solubility: Soluble in sterile water or bacteriostatic water for research purposes
Sequence: Ac-Ser-Tyr-Ser-Nle-GIu-His-D-Phe-Arg-Trp-GIy-Lys- Pro-Val-NH2

Research Applications:

MT-I is used in vitro to study:

Melanin production and pigmentation processes in melanocyte cells
Melanocortin receptor activity and related signaling pathways
Metabolic regulation via central melanocortin systems
Interactions between the nervous and immune systems, including inflammation
Differences and specificity among melanocortin receptor subtypes